|
|
 Acne (1,500)
Addictions (1,500)
Advice (1,500)
Allergies (1,092)
Alternative Medicine (1,500)
Anti Aging (1,500)
Breakup (1,500)
Cancer (1,499)
Dental Care (1,500)
Disabilities (1,500)
Divorce (1,500)
Elderly Care (1,498)
Goal Setting (1,500)
Hair Loss (1,500)
Health and Safety (1,497)
Hearing (1,500)
Law of Attraction (1,499)
Marriage (1,500)
Medicine (1,497)
Meditation (1,499)
Men's Health (1,500)
Mental Health (1,500)
Motivational (1,500)
Nutrition (1,495)
Personal Injury (1,499)
Plastic Surgeries (1,500)
Pregnancy (1,496)
Psychology (1,500)
Public Speaking (1,500)
Quit Smoking (1,500)
Religion (1,499)
Self Help (1,500)
Skin Care (1,500)
Sleep (1,500)
Stress Management (1,500)
Teenagers (1,492)
Time Management (1,500)
Weddings (1,500)
Wellness (1,500)
Women's Health (1,500)
Women's Issues (1,500)
|
Can-C eye drops safely reverse cataracts and are approved by the IVP for use on cataract suffering adults and backed by veterinarians for use on the common condition in senior dogs. The new treatment avoids the need for surgical removal of cataracts and high priced private surgery while offering affordability and acknowledged proven results.
Dr. Mark Babizhayev Ma, PhD has patented a clinically trialled eye drop that has been proven to reverse cataracts without the need for surgery. It uses the raw material N-Acetylcarnosine to reverse the damage of cataracts by simply applying several drops into the eye each day.
Statistically the United Kingdom has over 500,000 cataract suffers waiting for surgery at any one time. Just one London Hospital carries out 250 - 500 cataract surgeries every week. ?info_id=11" Can-C N-Acetylcarnosine eye drops is a safe and effective way to treat cataracts without the need for surgery.
As expected people in the international market place saw the opportunity to capitalise on this breakthrough and started to offer similar products that came with very poor results. Dr. Babizhayev voiced his concerns by saying "these companies often reference my research in their marketing efforts even though they have no affiliation with me and are definitely not offering my proprietary ?info_id=11" N-acetylcarnosine (Can-C) formulation which the research was based upon."
Fortunately there is a simple way for consumers to Verify if they have purchased the "Clinically Proven Formula" because each product has the statement "Approved by Innovative Vision Products (IVP)." printed directly on the box!
IVP is a Pharmaceutical and Nanotechnology Development Company with a portfolio of patent protected innovative chemical entities, drug delivery systems, and unique medical devices to target specific biomedical applications. Do Not be fooled by random formulations and claims from other companies.
Remarkably the success is not limited to humans as Can-C eye drops are available for Canine or ?info_id=13" Dog cataracts too. Happily, many dog owners are using this product to effectively address their pet's cataract condition including veterinarians.
Jack Stephans DVM of Pets Best Insurance said "as a veterinarian I want to let you know that I am recommending N-acetylcarnosine (Can-C) for the treatment of canine cataracts. After applying Can-C eye drops to my 15 year old miniature pinscher, "Skeeter", for one year, the cataract in his right eye has diminished! Your cataract eye drops are a modern scientific miracle for our pets."
Like Dr Stephans we all love our pets and would do most anything to help them enjoy their more senior years. Administering Can-C is safe, affordable and has no reported side effects backed by controlled clinical trials.
If you would like to read more about Dr. Mark Babizhayev, his research, testimonials or are a Physician, Veterinarian or Alternative Health Care Practitioner wishing to find out more then please visit the N-Acetylcarnosine (Can-C) ?info_id=11" Cataract Eye Drops website where there is detailed information and full scientific explanations on how Can-C works.
Contact:
Wise Choice Medicine
483 Green Lanes
London
England
N13 4BS
United Kingdom
This article is free to republish provided the resource box below remains intact.
|
|
|
